About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Nos2
nitric oxide synthase 2, inducible
MGI:97361
162 phenotypes from 7 alleles in 17 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Nos2em1(IMPC)Bay/Nos2em1(IMPC)Bay
C57BL/6N-Nos2em1(IMPC)Bay/Bay 		abnormal eye anterior chamber depth J:211773
decreased thigmotaxis J:211773
hyperactivity J:211773
Nos2tm1Lau/Nos2tm1Lau
B6.129P2-Nos2tm1Lau 		abnormal blood coagulation J:117987
abnormal bone mineralization J:112399
abnormal bone structure J:112399
abnormal corpus callosum morphology J:125459
abnormal eating behavior J:112153
abnormal frequency of paradoxical sleep J:83571
abnormal glucose homeostasis J:95957
abnormal heart morphology J:108269
abnormal heart ventricle morphology J:108269
abnormal myocardium layer morphology J:71505
abnormal osteoclast morphology J:112399
abnormal physiological neovascularization J:98135
abnormal platelet physiology J:117987
abnormal respiratory bronchiole morphology J:71505
abnormal respiratory system physiology J:71505
normal cardiovascular system phenotype J:106207
decreased oligodendrocyte number J:125459
decreased susceptibility to induced choroidal neovascularization J:106207
decreased susceptibility to induced colitis J:87601
decreased systemic arterial systolic blood pressure J:104749
enhanced central nervous system regeneration J:110081
enhanced wound healing J:110081
increased left ventricle developed pressure J:115413
increased mortality induced by ionizing radiation J:98135
increased susceptibility to pharmacologically induced seizures J:107300
normal mortality/aging J:115413
normal respiratory system phenotype J:71505
Nos2tm1Lau/Nos2tm1Lau
B6.129P2-Nos2tm1Lau/J 		abnormal brain wave pattern J:83571
abnormal circadian sleep/wake cycle J:83571
abnormal inflammatory response J:103018
abnormal sleep pattern J:83571
abnormal surfactant physiology J:130520
decreased inflammatory response J:103018
Nos2tm1Lau/Nos2tm1Lau
B6;129P2-Nos2tm1Lau/J 		decreased circulating alanine transaminase level J:148923
decreased circulating aspartate transaminase level J:148923
decreased susceptibility to injury J:148923
Nos2tm1Lau/Nos2tm1Lau
involves: 129P2/OlaHsd 		normal immune system phenotype J:55936
Nos2tm1Lau/Nos2tm1Lau
involves: 129P2/OlaHsd * C57BL/6 		abnormal adaptive immunity J:90903
abnormal blood homeostasis J:120673
abnormal enzyme/coenzyme level J:120673
abnormal fertilization J:112824
abnormal gametogenesis J:84347
abnormal immune system morphology J:90903
abnormal male meiosis J:84347
abnormal reproductive system morphology J:84347
abnormal systemic arterial blood pressure J:106197
abnormal testis morphology J:84347
abnormal tumor susceptibility J:93780
normal cardiovascular system phenotype J:36559
decreased circulating leptin level J:94571
decreased white adipose tissue amount J:94571
enlarged inguinal lymph nodes J:90903
enlarged seminiferous tubules J:84347
normal homeostasis/metabolism phenotype J:113106
normal immune system phenotype J:29677, J:64036
improved glucose tolerance J:72215
increased circulating antidiuretic hormone level J:106197
increased circulating creatinine level J:120673
increased food intake J:72215
increased growth rate J:72215
increased insulin sensitivity J:72215
increased single-positive T cell number J:90903
increased sperm number J:84347
increased susceptibility to bacterial infection J:100513
increased susceptibility to induced morbidity/mortality J:120673
increased T cell proliferation J:90903
increased testis weight J:84347
skin inflammation J:64036
Nos2tm1Lau/Nos2tm1Lau
involves: 129P2/OlaHsd * C57BL/6J 		increased urine pH J:64896
Nos2tm1Liew/Nos2tm1Liew
involves: 129 * 129P2/OlaHsd 		normal immune system phenotype J:118561
Nos2tm1Liew/Nos2tm1Liew
involves: 129P2/Ola * MF1 		abnormal T-helper 1 physiology J:25755
decreased inflammatory response J:25755
decreased susceptibility to endotoxin shock J:25755
increased interferon-gamma secretion J:25755
increased susceptibility to parasitic infection J:25755
increased T cell proliferation J:25755
Nos2tm1Mrl/Nos2tm1Mrl
B6.129S7-Nos2tm1Mrl 		abnormal involution of the mammary gland J:162957
abnormal mammary gland physiology J:162957
abnormal osteoclast differentiation J:98070
abnormal osteoclast morphology J:98070
abnormal response to infection J:98070
abnormal tooth hard tissue morphology J:98070
decreased bone resorption J:98070
decreased osteoclast cell number J:98070
hyperlactation J:162957
increased bone mineral density of femur J:98070
increased bone volume J:98070
increased circulating prolactin level J:162957
increased compact bone mass J:98070
Nos2tm1Mrl/Nos2tm1Mrl
either: 129S/Sv or B6J.129S7-Nos2tm1Mrl 		normal reproductive system phenotype J:73964
Nos2tm1Mrl/Nos2tm1Mrl
involves: 129S7/SvEvBrd 		abnormal bone healing J:123048
abnormal eosinophil cell number J:51635
abnormal heart right ventricle pressure J:57624
abnormal homeostasis J:51635
abnormal immune system physiology J:51635
abnormal induced retina neovascularization J:112024
abnormal macrophage physiology J:120499
abnormal platelet aggregation J:120499
abnormal trabecular bone morphology J:150159
abnormal vitreous body morphology J:112024
normal cardiovascular system phenotype J:57624
decreased eosinophil cell number J:51635
decreased survivor rate J:100308
decreased susceptibility to endotoxin shock J:25511
decreased urine prostaglandin level J:120499
delayed wound healing J:46763
increased body weight J:123048
increased IgG2a level J:51635
increased inflammatory response J:51635
increased interferon-gamma secretion J:51635
increased susceptibility to bacterial infection J:25511
premature death J:100308
Nos2tm1Mrl/Nos2tm1Mrl
involves: 129S7/SvEvBrd * C57BL/6 		abnormal adrenocorticotropin level J:109674
abnormal blood circulation J:65562
abnormal blood homeostasis J:97522
abnormal cardiovascular system morphology J:101254
abnormal cardiovascular system physiology J:97522
abnormal circulating estradiol level J:89542
abnormal circulating glucose level J:65562
abnormal circulating serum albumin level J:97522
abnormal digestion J:84264
abnormal glucose homeostasis J:65562
abnormal heart ventricle morphology J:101254
abnormal hormone level J:109674
abnormal motor capabilities/coordination/movement J:44287
abnormal peripheral nervous system regeneration J:104959
abnormal response to tactile stimuli J:104959
abnormal sensory capabilities/reflexes/nociception J:104959
abnormal thermal nociception J:104959
abnormal uterine artery morphology J:78274
abnormal uterus morphology J:78274
allodynia J:104959
atherosclerotic lesions J:97522
decreased adiponectin level J:155090
decreased cerebral infarct size J:44287
decreased digestive secretion J:142280
decreased litter size J:78274
decreased susceptibility to kidney reperfusion injury J:57621
delayed peripheral nervous system regeneration J:104959
normal homeostasis/metabolism phenotype J:65562, J:72215
improved glucose tolerance J:72215
increased body weight J:101254
increased circulating cholesterol level J:97522
increased circulating creatinine level J:97522
increased circulating triglyceride level J:155090
increased food intake J:72215
increased growth rate J:72215
increased insulin sensitivity J:72215
increased length of allograft survival J:54764
increased mean systemic arterial blood pressure J:87980
increased myocardial infarct size J:87980
increased renin activity J:155090
increased systemic arterial blood pressure J:87980
increased systemic arterial systolic blood pressure J:97522
liver fibrosis J:94156
normal nervous system phenotype J:104959
neuron degeneration J:104959
pancreas inflammation J:65562
prolonged diestrus J:89542
Nos2tm1Mrl/Nos2tm1Mrl
involves: 129S7/SvEvBrd * PL/J 		increased susceptibility to experimental autoimmune encephalomyelitis J:46192
Tg(Alb-Nos2)1Mkan/?
FVB-Tg(Alb-Nos2)1Mkan 		abnormal glucose homeostasis J:177591
abnormal glycogen homeostasis J:177591
normal behavior/neurological phenotype J:177591
decreased liver glycogen level J:177591
hyperglycemia J:177591
increased circulating triglyceride level J:177591
increased circulating VLDL triglyceride level J:177591
increased liver triglyceride level J:177591
increased triglyceride level J:177591
Tg(Ins2-Nos2)31Okam/0
involves: C57BL/6 * CD-1 * DBA/2 		abnormal nitric oxide homeostasis J:45520
abnormal pancreas morphology J:45520
abnormal pancreatic islet morphology J:45520
decreased circulating insulin level J:45520
decreased pancreatic beta cell mass J:45520
hyperglycemia J:45520
increased urine glucose level J:45520
ketoaciduria J:45520
Tg(Ins2-Nos2)40Okam/0
involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2 		abnormal kidney morphology J:116040
abnormal renal glomerulus morphology J:116040
albuminuria J:116040
hyperglycemia J:116040
increased circulating creatinine level J:116040
increased kidney weight J:116040
Tg(Ins2-Nos2)40Okam/0
involves: C57BL/6 * CD-1 * DBA/2 		abnormal nitric oxide homeostasis J:45520
abnormal pancreatic islet morphology J:45520
decreased circulating insulin level J:45520
decreased pancreatic beta cell mass J:45520
hyperglycemia J:45520
increased circulating ketone body level J:45520
increased urine glucose level J:45520
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory